Massachusetts Drug Development Certification
Exam question with correct answers (100%
verified answers) plus rationales Q &A
2026 INSTANT DOWNLOAD PDF
1. What is the first phase of drug development?
A. Phase III trials
B. Preclinical research
C. Post-marketing surveillance
D. Phase II trials
Answer: B
Preclinical research involves laboratory and animal testing before human trials
begin.
2. Which agency regulates drug approval in the United States?
A. WHO
B. CDC
C. FDA
D. DEA
Answer: C
The FDA oversees safety, efficacy, and approval of drugs.
3. What is the main goal of Phase I clinical trials?
,A. Test effectiveness
B. Determine safety and dosage
C. Compare with placebo
D. Mass production
Answer: B
Phase I focuses on safety, dosage range, and side effects in humans.
4. Which study phase involves large patient populations?
A. Phase I
B. Phase II
C. Phase III
D. Phase IV
Answer: C
Phase III confirms effectiveness in large groups.
5. What is pharmacovigilance?
A. Drug synthesis
B. Monitoring drug safety after approval
C. Clinical trial design
D. Drug marketing
Answer: B
It tracks adverse drug reactions after market release.
6. What is an IND application?
A. Investigational New Drug application
B. International New Drug approval
C. Inactive Drug Notice
D. Industrial Drug Network
,Answer: A
IND allows testing of a new drug in humans.
7. What is the purpose of a placebo in clinical trials?
A. Cure disease
B. Serve as control
C. Increase dosage
D. Replace drug
Answer: B
A placebo helps compare drug effectiveness.
8. What does GMP stand for?
A. General Medical Practice
B. Good Manufacturing Practice
C. Global Medicine Protocol
D. Genetic Modification Process
Answer: B
GMP ensures drugs are consistently produced with quality standards.
9. Which phase detects rare side effects?
A. Phase I
B. Phase II
C. Phase III
D. Phase IV
Answer: D
Post-marketing surveillance identifies rare adverse effects.
10. What is bioavailability?
, A. Drug price
B. Rate of drug absorption
C. Drug packaging
D. Drug marketing
Answer: B
It measures how much drug reaches circulation.
11. What is a clinical trial protocol?
A. Marketing plan
B. Study design document
C. Drug label
D. Prescription guide
Answer: B
It outlines how a clinical trial is conducted.
12. What is randomization in trials?
A. Assigning patients randomly
B. Choosing drug dose
C. Selecting hospitals
D. Manufacturing drugs
Answer: A
It reduces bias in clinical studies.
13. What is double-blind study design?
A. Only patient blinded
B. Only doctor blinded
C. Both patient and researcher unaware
D. No blinding
Exam question with correct answers (100%
verified answers) plus rationales Q &A
2026 INSTANT DOWNLOAD PDF
1. What is the first phase of drug development?
A. Phase III trials
B. Preclinical research
C. Post-marketing surveillance
D. Phase II trials
Answer: B
Preclinical research involves laboratory and animal testing before human trials
begin.
2. Which agency regulates drug approval in the United States?
A. WHO
B. CDC
C. FDA
D. DEA
Answer: C
The FDA oversees safety, efficacy, and approval of drugs.
3. What is the main goal of Phase I clinical trials?
,A. Test effectiveness
B. Determine safety and dosage
C. Compare with placebo
D. Mass production
Answer: B
Phase I focuses on safety, dosage range, and side effects in humans.
4. Which study phase involves large patient populations?
A. Phase I
B. Phase II
C. Phase III
D. Phase IV
Answer: C
Phase III confirms effectiveness in large groups.
5. What is pharmacovigilance?
A. Drug synthesis
B. Monitoring drug safety after approval
C. Clinical trial design
D. Drug marketing
Answer: B
It tracks adverse drug reactions after market release.
6. What is an IND application?
A. Investigational New Drug application
B. International New Drug approval
C. Inactive Drug Notice
D. Industrial Drug Network
,Answer: A
IND allows testing of a new drug in humans.
7. What is the purpose of a placebo in clinical trials?
A. Cure disease
B. Serve as control
C. Increase dosage
D. Replace drug
Answer: B
A placebo helps compare drug effectiveness.
8. What does GMP stand for?
A. General Medical Practice
B. Good Manufacturing Practice
C. Global Medicine Protocol
D. Genetic Modification Process
Answer: B
GMP ensures drugs are consistently produced with quality standards.
9. Which phase detects rare side effects?
A. Phase I
B. Phase II
C. Phase III
D. Phase IV
Answer: D
Post-marketing surveillance identifies rare adverse effects.
10. What is bioavailability?
, A. Drug price
B. Rate of drug absorption
C. Drug packaging
D. Drug marketing
Answer: B
It measures how much drug reaches circulation.
11. What is a clinical trial protocol?
A. Marketing plan
B. Study design document
C. Drug label
D. Prescription guide
Answer: B
It outlines how a clinical trial is conducted.
12. What is randomization in trials?
A. Assigning patients randomly
B. Choosing drug dose
C. Selecting hospitals
D. Manufacturing drugs
Answer: A
It reduces bias in clinical studies.
13. What is double-blind study design?
A. Only patient blinded
B. Only doctor blinded
C. Both patient and researcher unaware
D. No blinding
